tirzepatide for obstructive sleep apnea and glp-1 medication is known to improve apnea, but not all patients Original Article: Tirzepatide for the

Kaiser added conditional coverage in most of its regional formularies following that approval, but the pathway demands more documentation than a typical commercial plan

March 2, 2026 NAION Warning In the U.K., the Medicines and Healthcare products Regulatory Agency has issued a safety update warning that semaglutide, the widely used diabetes and weight loss drug sold as Wegovy, Ozempic and Rybelsus, may be linked in rare cases to a serious eye condition that can cause sudden vision loss

Treatment with liraglutide altered the gut microbiota community in diabetic male rats, leading to an increase in Bacteroides , members of the family Lachnospiraceae , and the beneficial genus Bifidobacterium , which was linked to lowered intestinal inflammation and improved glycemic control (27)

Wang, Q., Sun, Z